Try a new search

Format these results:

Searched for:

person:ed891

in-biosketch:true

Total Results:

7


Association between Ovarian Endometriomas and Stage of Endometriosis

Seraji, Shadi; Ali, Aliyah; Demirel, Esra; Akerman, Meredith; Nezhat, Camran; Nezhat, Farr R
PMCID:11313643
PMID: 39124796
ISSN: 2077-0383
CID: 5731022

Laparoscopic Diagnosis and Treatment of an Isolated Cervical Diverticulum [Case Report]

Nezhat, Farr; Demirel, Esra; Mesbah, Michael; Hill, Kaitlyn
BACKGROUND:Congenital müllerian anomalies are found in 8.0% of women with infertility and up to 5.5% of women in a general population. Cervical diverticulum is a type of cervical malformation that can be congenital or acquired, with only select cases documented in the literature. Cervical diverticulum can be asymptomatic or present with abnormal uterine bleeding, pelvic pain, or infertility. Previously described management options are largely limited to observation or exploratory laparotomy. CASE:A 35-year-old woman, gravida 2 para 2, presented with persistent menorrhagia, pelvic pain, and abdominal bloating and was found to have an 8-cm right adnexal mass on pelvic ultrasonography. Magnetic resonance imaging showed a hemorrhagic cervical mass communicating with the uterine cavity. The mass was resected laparoscopically, and pathology revealed fibromuscular tissue with endocervical epithelium consistent with a cervical diverticulum. CONCLUSION:Isolated cervical diverticula are rare but should be considered in the differential diagnosis of adnexal masses. Laparoscopic surgery is a safe, minimally invasive approach for evaluation and repair of cervical diverticula.
PMID: 37023456
ISSN: 1873-233x
CID: 5507862

The Plasminogen Activator System, Glucocorticoid, and Mineralocorticoid Receptors in the Primate Endometrium During Artificial Menstrual Cycles

Demirel, Esra; Sabouni, Reem; Chandra, Neelima; Slayden, Ov D; Archer, David F
As a key mechanism in fibrinolysis and tissue remodeling, the plasminogen activator system has been suggested in the process of endometrial shedding and tissue remodeling. Previous studies have explored the role of estrogen, progesterone, and androgen receptors as well as elements of the renin-angiotensin-aldosterone system in shaping the morphology of the endometrium. This study investigates the distribution and concentrations of the mineralocorticoid receptor, glucocorticoid receptor, tissue plasminogen activator, urokinase plasminogen activator, and plasminogen activator inhibitor-1 within the endometrial stroma, glandular, and endothelial cells of the primate endometrium during artificial menstrual cycles. Our immunohistochemistry quantification shows mineralocorticoid and glucocorticoid receptors are ubiquitously distributed within the macaque endometrium with their patterns of expression following similar fluctuations to urokinase and tissue plasminogen activators particularly within the endometrial vasculature. These proteins are present in endometrial vasculature in high levels during the proliferative phase, decreasing levels during the secretory phase followed by rising levels in the menstrual phase. These similarities could suggest overlapping pathways and interactions between the plasminogen activator system and the steroid receptors within the endometrium. Given the anti-inflammatory properties of glucocorticoids and the role of plasminogen activators in endometrial breakdown, the glucocorticoid receptor may be contributing to stabilizing the endometrium by regulating plasminogen activators during the proliferative phase and menstruation. Furthermore, given the anti-mineralocorticoid properties of certain anti-androgenic progestins and their reduced unscheduled uterine bleeding patterns, the mineralocorticoid receptor may be involved in unscheduled endometrial bleeding.
PMCID:8863636
PMID: 34796470
ISSN: 1933-7205
CID: 5675282

Hidden Burden of Fallopian Tube Endometriosis: Prevalence and Associations with Pelvic Pathology

Nezhat, Farr; Rashidian, Pegah; Seraji, Shadi; Demirel, Esra; Islam, Shahidul; Khullar, Poonam; Nezhat, Camran
PMCID:12898751
PMID: 41682817
ISSN: 2077-0383
CID: 6002512

Management of high-grade ovarian adenocarcinoma in an intraperitoneal pelvic renal transplant recipient

Erfani, Hadi; Demirel, Esra; Nezhat, Farr
BACKGROUND/UNASSIGNED:The increasing number of organ transplant recipients has led to a rise in cancer diagnoses in this population. Kidney transplant recipients, in particular, have a two-to-four-fold higher risk of developing cancer due to immunosuppressive therapy. The management of gynecologic cancers in this subset of patients presents unique challenges due to anatomical considerations, immunosuppression, and the nephrotoxicity of oncologic treatments.Case Presentation.A 44-year-old woman with a history of polycystic kidney disease underwent a bilateral nephrectomy followed by a living-related intraperitoneal renal transplant. She presented with pelvic pain and was found to have high-grade ovarian adenocarcinoma, possibly arising from endometriosis. Surgical staging included total laparoscopic hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and right pelvic lymph node dissection. The patient underwent six cycles of carboplatin and paclitaxel chemotherapy while maintaining stable renal function with close monitoring of immunosuppressive drug levels. Surveillance imaging detected recurrence in the right pelvic lymph nodes, leading to secondary tumor debulking and whole pelvic radiation therapy. Despite a slight increase in creatinine, kidney function remained stable, and the patient has remained disease-free on subsequent follow-ups. CONCLUSION/UNASSIGNED:The management of ovarian cancer in kidney transplant recipients requires a multidisciplinary approach to balance oncologic control with graft preservation. Close monitoring of renal function, careful surgical planning, and tailored chemotherapy and radiation strategies are critical. More research is needed to establish standardized guidelines for managing gynecologic malignancies in transplant patients.
PMCID:12134479
PMID: 40469881
ISSN: 2352-5789
CID: 5862642

Reproductive Outcomes After Laparoscopic Treatment of Endometriosis in Women with Infertility

Azmoudeh, Yaas; Nezhat, Farr R; Talebian, Sheeva; Palter, Steven; Tortoriello, Drew; Ali, Aliyah; Demirel, Esra; Akerman, Meredith; Nezhat, Ceana; Nezhat, Camran
OBJECTIVE/UNASSIGNED:To assess the impact of laparoscopic treatment of endometriosis on pregnancy outcomes in women with infertility, performed either before or after failed fertility enhancement technology (FET). Secondary aims included evaluating the influence of age, body mass index (BMI), prior pregnancies, endometriosis stage, and the presence of endometriomas on reproductive outcomes. DESIGN/UNASSIGNED:Retrospective cohort study of 95 women aged 18-45 with primary or secondary infertility who underwent treatment of endometriosis laparoscopically with or without robotic assistance between January 2015 and January 2023. All surgeries were performed by a single gynecologic surgeon. Patients were grouped based on whether they had prior FET failure or no prior FET. Comparisons were made between pregnant and nonpregnant patients across both groups. MAIN OUTCOME MEASURES/UNASSIGNED:Postsurgical pregnancy rates (spontaneous vs assisted reproductive technology [ART]) and factors associated with pregnancy outcomes, including age, BMI, endometriosis stage, and presence of endometriomas. RESULTS/UNASSIGNED:= .011). Endometriosis stage did not significantly influence outcomes. Patients with endometriomas were more likely to be referred for surgery before FET. CONCLUSIONS/UNASSIGNED:Laparoscopic surgery for endometriosis is associated with high pregnancy rates, regardless of prior FET status. These findings support the role of surgery as a key component in fertility management for women with endometriosis, especially prior to initiating FET.
PMCID:12668380
PMID: 41334485
ISSN: 1938-3797
CID: 5974922

Management of high-grade ovarian adenocarcinoma in an intraperitoneal pelvic renal transplant recipient [Case Report]

Demirel, Esra; Cohen, Seth; Ennis, Ronald D; Nezhat, Farr R
BACKGROUND/UNASSIGNED:Number of organ transplant recipients continues to rise worldwide with increasing accessibility and growing advancements in transplant medicine. Transplant patients have at least a two-to-four fold higher risk of developing cancer compared to the general population. As the prevalence of transplant patients increases, a growing number of these patients are expected to present with concurrent conditions such as cancer, requiring more complex and interdisciplinary care. CASE/UNASSIGNED:A 44-year-old patient with an intraperitoneal pelvic renal transplant, found to have high-grade ovarian adenocarcinoma most likely arising from endometriosis, successfully underwent surgical staging, adjuvant chemotherapy, and subsequent pelvic radiation for recurrence. Her kidney function and graft viability were preserved throughout her treatment with careful monitoring. CONCLUSION/UNASSIGNED:Management of reproductive tract cancers in kidney transplant recipients is complex. Current practices largely rely on evidence from observational studies and case reports for these cancers and more research is needed in this area.
PMCID:11399701
PMID: 39281843
ISSN: 2352-5789
CID: 5719782